Table 3.
Drugs | Triggered Disease | Evidence Level* | References |
---|---|---|---|
Antibiotics | |||
Vancomycin | LAD | 3 | [189-203] |
Trimethoprim-sulfamethoxazole | LAD | 3 | [204] |
Penicillin G | LAD, anti-p200 | 3 | [205, 206] |
Ampicillin-Sulbactam | LAD | 3 | [207] |
Lithium carbonate | LAD | 3 | [208] |
Phenytoin | LAD | 3 | [189] |
Amiodarone | LAD | 3 | [209] |
Atorvastatin | LAD | 3 | [210] |
Nonsteroidal Anti-Inflammatory Drugs | |||
Acetylsalicylic acid | BP | 3 | [211] |
Diclofenac | LAD | 3 | [212, 213] |
Penicillamine | PV, PF, PE, BP, MMP, EBA | 3 | [214, 215] |
PUVA | BP, PV, PF | 3 | [216-220] |
UV | PF, BP, EBA | 3 | [221-223] |
From Scottish Intercollegiate Guidelines Network (SIGN; http://www.sign.ac.uk/guidelines/fulltext/50/annexb.html).